Authors:
Bentires-Alj, M
Dejardin, E
Viatour, P
Van Lint, C
Froesch, B
Reed, JC
Merville, MP
Bours, V
Citation: M. Bentires-alj et al., Inhibition of the NF-kappa B transcription factor increases Bax expressionin cancer cell lines, ONCOGENE, 20(22), 2001, pp. 2805-2813
Authors:
Mami-Chouaib, F
Ameyar, M
Dorothee, G
Bentires-Alj, M
Dziembowska, M
Delhalle, S
Gay, F
Stancou, R
Bours, V
Chouaib, S
Citation: F. Mami-chouaib et al., Effect of nuclear factor kappa B inhibition on tumor cell sensitivity to natural killer-mediated cytolytic function, EUR J IMMUN, 31(2), 2001, pp. 433-439
Authors:
Bureau, F
Bonizzi, G
Kirschvink, N
Delhalle, S
Desmecht, D
Merville, MP
Bours, V
Lekeux, P
Citation: F. Bureau et al., Correlation between nuclear factor-kappa B activity in bronchial brushing samples and lung dysfunction in an animal model of asthma, AM J R CRIT, 161(4), 2000, pp. 1314-1321
Authors:
Princen, F
Lechanteur, C
Lopez, M
Gielen, J
Bours, V
Merville, MP
Citation: F. Princen et al., Similar efficiency of DNA-liposome complexes and retrovirus-producing cells for HSV-tk suicide gene therapy of peritoneal carcinomatosis, J DRUG TAR, 8(2), 2000, pp. 79-89
Authors:
Robe, PA
Rogister, B
Merville, MP
Bours, V
Citation: Pa. Robe et al., Growth regulation of astrocytes and C6 cells by TGF beta I: correlation with gap junctions, NEUROREPORT, 11(13), 2000, pp. 2837-2841
Authors:
Benoit, V
Hellin, AC
Huygen, S
Gielen, J
Bours, V
Merville, MP
Citation: V. Benoit et al., Additive effect between NF-kappa B subunits and p53 protein for transcriptional activation of human p53 promoter, ONCOGENE, 19(41), 2000, pp. 4787-4794
Authors:
Lechanteur, C
Moutschen, M
Princen, F
Lopez, M
Franzen, E
Gielen, J
Bours, V
Merville, MP
Citation: C. Lechanteur et al., Antitumoral vaccination with granulocyte-macrophage colony-stimulating factor or interleukin-12-expressing DHD/K12 colon adenocarcinoma cells, CANC GENE T, 7(5), 2000, pp. 676-682
Authors:
Bours, V
Bonizzi, G
Bentires-Alj, M
Bureau, F
Piette, J
Lekeux, P
Merville, MP
Citation: V. Bours et al., NF-kappa B activation in response to toxical and therapeutical agents: role in inflammation and cancer treatment, TOXICOLOGY, 153(1-3), 2000, pp. 27-38
Authors:
Locigno, R
Antoine, N
Bours, V
Daukandt, M
Heinen, E
Castronovo, V
Citation: R. Locigno et al., TNP-470, a potent angiogenesis inhibitor, amplifies human T lymphocyte activation through an induction of nuclear factor-kappa B, nuclear factor-AT, and activation protein-1 transcription factors, LAB INV, 80(1), 2000, pp. 13-21
Authors:
Hellin, AC
Bentires-Alj, M
Verlaet, M
Benoit, V
Gielen, J
Bours, V
Merville, MP
Citation: Ac. Hellin et al., Roles of nuclear factor-kappa B, p53, and p21/WAF1 in daunomycin-induced cell cycle arrest and apoptosis, J PHARM EXP, 295(3), 2000, pp. 870-878
Authors:
Bureau, F
Delhalle, S
Bonizzi, G
Fievez, L
Dogne, S
Kirschvink, N
Vanderplasschen, A
Merville, MP
Bours, V
Lekeux, P
Citation: F. Bureau et al., Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthma, J IMMUNOL, 165(10), 2000, pp. 5822-5830
Authors:
Robe, PA
Princen, F
Martin, D
Malgrange, B
Stevenaert, A
Moonen, G
Gielen, J
Merville, MP
Bours, V
Citation: Pa. Robe et al., Pharmacological modulation of the bystander effect in the herpes simplex virus thymidine kinase/ganciclovir gene therapy system - Effects of dibutyryl adenosine 3 ',5 '-cyclic monophosphate, A-glycyrrhetinic acid, and cytosine arabinoside, BIOCH PHARM, 60(2), 2000, pp. 241-249
Authors:
Bonizzi, G
Piette, J
Merville, MP
Bours, V
Citation: G. Bonizzi et al., Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1, BIOCH PHARM, 59(1), 2000, pp. 7-11
Authors:
Princen, F
Robe, P
Lechanteur, C
Mesnil, M
Rigo, JM
Gielen, J
Merville, MP
Bours, V
Citation: F. Princen et al., A cell type-specific and gap junction-independent mechanism for the herpessimplex virus-1 Thymidine kinase gene/ganciclovir-mediated bystander effect, CLIN CANC R, 5(11), 1999, pp. 3639-3644
Authors:
Chariot, A
van Lint, C
Chapelier, M
Gielen, J
Merville, MP
Bours, V
Citation: A. Chariot et al., CBP and histone deacetylase inhibition enhance the transactivation potential of the HOXB7 homeodomain-containing protein, ONCOGENE, 18(27), 1999, pp. 4007-4014
Authors:
Dejardin, E
Deregowski, V
Chapelier, M
Jacobs, N
Gielen, J
Merville, MP
Bours, V
Citation: E. Dejardin et al., Regulation of NF-kappa B activity by I kappa B-related proteins in adenocarcinoma cells, ONCOGENE, 18(16), 1999, pp. 2567-2577
Authors:
Sautois, B
Fraipont, V
Baudoux, E
Fassotte, MF
Hermanne, JP
Jerusalem, G
Bours, V
Bosquee, L
Schaaf-Lafontaine, N
Paulus, JM
Sondag, D
Fillet, G
Beguin, Y
Citation: B. Sautois et al., Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields, HAEMATOLOG, 84(4), 1999, pp. 342-349
Authors:
Bonizzi, G
Piette, J
Schoonbroodt, S
Greimers, R
Havard, L
Merville, MP
Bours, V
Citation: G. Bonizzi et al., Reactive oxygen intermediate-dependent NF-kappa B activation by interleukin-1 beta requires 5-lipoxygenase or NADPH oxidase activity, MOL CELL B, 19(3), 1999, pp. 1950-1960
Authors:
Chariot, A
Princen, F
Gielen, J
Merville, MP
Franzoso, G
Brown, K
Siebenlist, U
Bours, V
Citation: A. Chariot et al., I kappa B-alpha enhances transactivation by the HOXB7 homeodomain-containing protein, J BIOL CHEM, 274(9), 1999, pp. 5318-5325